The International Finance Corporation (IFC), a member of the World Bank Group, has approved a $30.7 million loan to Popular Pharmaceuticals PLC (Popular Pharma), a leading Bangladeshi pharmaceutical company. The financing is intended to support the import of raw materials for the production of essential medicines.
The loan was announced on August 20, 2026, according to IFC's disclosure. The funds will be used to finance the import of active pharmaceutical ingredients (APIs) and other raw materials needed for manufacturing, helping to ensure the continuity of drug supply in Bangladesh.
Popular Pharma, based in Dhaka, is one of the country's largest drug manufacturers. The company has been expanding its production capacity and export footprint in recent years. The IFC loan is part of the institution's broader strategy to strengthen healthcare systems in emerging markets.
Neither IFC nor Popular Pharma has disclosed the interest rate or repayment terms of the loan. The transaction is subject to customary closing conditions.
